Logo image of BRN

BARNWELL INDUSTRIES INC (BRN) Stock Fundamental Analysis

NYSEARCA:BRN - NYSE Arca - US0682211000 - Common Stock - Currency: USD

1.19  -0.04 (-3.25%)

Fundamental Rating

2

Overall BRN gets a fundamental rating of 2 out of 10. We evaluated BRN against 213 industry peers in the Oil, Gas & Consumable Fuels industry. BRN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. BRN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year BRN has reported negative net income.
BRN had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BRN reported negative net income in multiple years.
Each year in the past 5 years BRN had a positive operating cash flow.
BRN Yearly Net Income VS EBIT VS OCF VS FCFBRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M

1.2 Ratios

With a Return On Assets value of -25.65%, BRN is not doing good in the industry: 92.96% of the companies in the same industry are doing better.
The Return On Equity of BRN (-61.70%) is worse than 87.79% of its industry peers.
Industry RankSector Rank
ROA -25.65%
ROE -61.7%
ROIC N/A
ROA(3y)-2.01%
ROA(5y)-2.36%
ROE(3y)-6.33%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BRN Yearly ROA, ROE, ROICBRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600 -800 -1K

1.3 Margins

BRN has a Gross Margin of 33.54%. This is comparable to the rest of the industry: BRN outperforms 43.66% of its industry peers.
BRN's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for BRN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.64%
GM growth 5Y15.73%
BRN Yearly Profit, Operating, Gross MarginsBRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

4

2. Health

2.1 Basic Checks

BRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
BRN has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BRN has been increased compared to 5 years ago.
BRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BRN Yearly Shares OutstandingBRN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
BRN Yearly Total Debt VS Total AssetsBRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of 0.52, we must say that BRN is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of BRN (0.52) is worse than 64.79% of its industry peers.
There is no outstanding debt for BRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.52
ROIC/WACCN/A
WACC9.85%
BRN Yearly LT Debt VS Equity VS FCFBRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M

2.3 Liquidity

BRN has a Current Ratio of 0.99. This is a bad value and indicates that BRN is not financially healthy enough and could expect problems in meeting its short term obligations.
BRN's Current ratio of 0.99 is in line compared to the rest of the industry. BRN outperforms 40.85% of its industry peers.
BRN has a Quick Ratio of 0.99. This is a bad value and indicates that BRN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.99, BRN perfoms like the industry average, outperforming 51.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.99
BRN Yearly Current Assets VS Current LiabilitesBRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for BRN have decreased strongly by -91.78% in the last year.
BRN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -25.45%.
BRN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.94% yearly.
EPS 1Y (TTM)-91.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32.17%
Revenue 1Y (TTM)-25.45%
Revenue growth 3Y9.03%
Revenue growth 5Y11.94%
Sales Q2Q%-32.33%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BRN Yearly Revenue VS EstimatesBRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BRN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BRN Price Earnings VS Forward Price EarningsBRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BRN Per share dataBRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

BRN has a Yearly Dividend Yield of 2.31%.
Compared to an average industry Dividend Yield of 6.81, BRN has a dividend in line with its industry peers.
BRN's Dividend Yield is comparable with the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 2.31%

5.2 History

BRN has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BRN Yearly Dividends per shareBRN Yearly Dividends per shareYearly Dividends per share 2022 2023 0.01 0.02 0.03 0.04 0.05

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
BRN Yearly Income VS Free CF VS DividendBRN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M

More info and screens

BARNWELL INDUSTRIES INC

NYSEARCA:BRN (6/5/2025, 8:04:01 PM)

1.19

-0.04 (-3.25%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-15 2025-05-15
Earnings (Next)08-11 2025-08-11
Inst Owners12.68%
Inst Owner Change-2.63%
Ins Owners56.96%
Ins Owner Change1.87%
Market Cap11.96M
Analysts0
Price TargetN/A
Short Float %0.05%
Short Ratio0.29
Dividend
Industry RankSector Rank
Dividend Yield 2.31%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.67
P/FCF N/A
P/OCF 7.98
P/B 1.18
P/tB 1.18
EV/EBITDA N/A
EPS(TTM)-0.62
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.3
FCFYN/A
OCF(TTM)0.15
OCFY12.53%
SpS1.78
BVpS1.01
TBVpS1.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.65%
ROE -61.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.54%
FCFM N/A
ROA(3y)-2.01%
ROA(5y)-2.36%
ROE(3y)-6.33%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.64%
GM growth 5Y15.73%
F-Score4
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 117.66%
Cap/Sales 25.46%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.99
Quick Ratio 0.99
Altman-Z 0.52
F-Score4
WACC9.85%
ROIC/WACCN/A
Cap/Depr(3y)232.65%
Cap/Depr(5y)208.92%
Cap/Sales(3y)33.56%
Cap/Sales(5y)25.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-91.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32.17%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-25.45%
Revenue growth 3Y9.03%
Revenue growth 5Y11.94%
Sales Q2Q%-32.33%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-35.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y31.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-76.3%
OCF growth 3Y78.3%
OCF growth 5YN/A